Free Trial

Ameritas Advisory Services LLC Sells 580 Shares of Intuitive Surgical, Inc. $ISRG

Intuitive Surgical logo with Medical background

Key Points

  • Ameritas Advisory Services LLC reduced its stake in Intuitive Surgical by 33.6%, now holding 1,144 shares worth approximately $622,000.
  • Analysts have mixed opinions on Intuitive Surgical, with ratings ranging from “strong-buy” to “hold”; the average target price is $594.19.
  • In the last quarter, an executive sold a substantial amount of stock, reducing their holdings by 92.73%, highlighting significant insider selling activity.
  • MarketBeat previews top five stocks to own in November.

Ameritas Advisory Services LLC lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 33.6% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,144 shares of the medical equipment provider's stock after selling 580 shares during the quarter. Ameritas Advisory Services LLC's holdings in Intuitive Surgical were worth $622,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Brighton Jones LLC raised its position in Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after purchasing an additional 731 shares during the last quarter. NBC Securities Inc. bought a new position in Intuitive Surgical in the 1st quarter valued at approximately $135,000. Vest Financial LLC boosted its position in Intuitive Surgical by 73.5% during the 1st quarter. Vest Financial LLC now owns 4,728 shares of the medical equipment provider's stock worth $2,342,000 after buying an additional 2,003 shares during the period. Pines Wealth Management LLC bought a new stake in Intuitive Surgical during the 1st quarter worth approximately $216,000. Finally, Sivia Capital Partners LLC increased its position in Intuitive Surgical by 7.5% in the 1st quarter. Sivia Capital Partners LLC now owns 894 shares of the medical equipment provider's stock valued at $443,000 after acquiring an additional 62 shares during the period. 83.64% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the company. BTIG Research restated a "buy" rating and issued a $571.00 price objective on shares of Intuitive Surgical in a report on Wednesday, October 1st. The Goldman Sachs Group lowered their price objective on Intuitive Surgical from $621.00 to $567.00 and set a "buy" rating for the company in a research report on Wednesday, October 1st. Truist Financial upped their target price on Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a report on Wednesday, July 23rd. Zacks Research lowered shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 20th. Finally, Wall Street Zen raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday. Fourteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average target price of $594.19.

View Our Latest Stock Report on Intuitive Surgical

Intuitive Surgical Trading Up 2.1%

Shares of Intuitive Surgical stock opened at $452.35 on Monday. The company has a market capitalization of $162.16 billion, a P/E ratio of 63.09, a price-to-earnings-growth ratio of 4.74 and a beta of 1.61. The stock has a fifty day simple moving average of $463.55 and a 200 day simple moving average of $500.11. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same period in the previous year, the firm earned $1.78 EPS. The business's revenue for the quarter was up 21.4% compared to the same quarter last year. On average, analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling

In other news, EVP Myriam Curet sold 4,500 shares of the company's stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares of the company's stock, valued at $173,845.44. This represents a 92.73% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Amy L. Ladd sold 336 shares of the company's stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the sale, the director directly owned 1,074 shares in the company, valued at approximately $504,898.14. This trade represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 45,224 shares of company stock valued at $21,716,492. 0.70% of the stock is owned by insiders.

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Further Reading

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Intuitive Surgical Right Now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.